Biotech, Food, Drug

The food we eat and the medicine we put into our bodies are highly regulated by a variety of government agencies. In the United States by the Food and Drug Administration (FDA) and the United States Department of Agriculture (USDA) regulate the processes by which food makes its way to the grocery store and medicine is approved for consumer use.  As the science grows more complex behind the pharmaceutical and food industry, interpretation of the regulations in place is becoming more nuanced.  Overseas, these industries are regulated by a variety of agencies; for example, the Minister of Agriculture in Canada, Centre for Food Safety in Hong Kong, and the Committee of Environmental, Public Health and Food Safety (EU), are among the many governing-bodies which regulate biotechnology, food, and drugs throughout the world.

The National Law Review is your free online resource to agency news, emerging topics in food and drug, and the latest in biotechnology updates. From nanotechnologies being used in research, to regulations of imported foods coming into the US from overseas or the development of medical devices and drugs, readers can find expert legal analysis of the developments in the industry, as well as reports on changes within the agencies that regulate these industries. The National Law Review also covers topics related to licensing, Food Safety and Inspection Services (FSIS), food and beverage regulation in the US and worldwide, nutrition labeling, and country of origin labeling guidelines.

With recent legislation being passed throughout the US in relation to marijuana use, both for recreational and medicinal purposes, readers will also find up-to-date information, litigation, and news coming from this area of interest as well. Regulations in California for labeling and proper sales of marijuana, to use in different states, or internationally, as well as rules for promoting and advertising marijuana are also covered on the site. Additionally, the development and changing landscape of tobacco use to include vaping, and how e-cigarettes and vaping are regulated, is also covered by NLR authors.

Readers who are interested in food safety, inspection, imports into the US, and regulations, these topics are covered regularly on The National Law Review as well. New legislation from the FDA, USDA, Department of Agriculture, and international bodies, are covered on the site. If you are looking for details on new nutrition-labeling regulations or health risks of consuming certain imported foods, you will find these topics, and many more, on The National Law Review.

For hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis Twitter feed, and sign up for complimentary e-news bulletins.

Custom text Title Sort descending Organization
May
13
2022
A New(ish) Chemical Excise Tax Effective July 2022 Proskauer Rose LLP
Jun
14
2018
A Pom Wonderful World: F&B Makers’ New Adversary Bilzin Sumberg
Apr
12
2019
A Practical Guide for Multistate Employers on Managing the Growing Patchwork of Marijuana Laws Bracewell LLP
Mar
14
2016
A Practical Understanding of the Polymer Exemption Keller and Heckman LLP
Mar
15
2017
A Prior Art Reference that Merely Suggests the Claimed Subject Matter Does Not Anticipate the Claims Hunton Andrews Kurth
Apr
12
2018
A pro-active approach to doping – raising the bar at the Commonwealth Games Squire Patton Boggs (US) LLP
Mar
21
2024
A Psychedelic Use Case for AI Nelson Mullins
Mar
11
2020
A Recipe for Disaster: The Impact of COVID-19 on Food Safety and the Food Industry Bilzin Sumberg
Nov
23
2020
A Record-Breaking Year in Digital Health Investments: Key Takeaways | HTLH GoLive Webinar Foley & Lardner LLP
Nov
4
2021
A Reminder of Doctrine of Equivalents in Biotechnology: Jennewein Biotechnologie GmbH v. International Trade Commission Proskauer Rose LLP
Nov
20
2014
A Report from the “Biosimilars and Biotech: MENA Conference” in Istanbul, Turkey: Part 1 Michael Best & Friedrich LLP
Oct
27
2014
A Review of the Status of Biosimilars in the U.S. Michael Best & Friedrich LLP
Oct
31
2022
A Safety Warning May Be Required for Black Licorice Used in Compliance with a GRAS Regulation Keller and Heckman LLP
Sep
28
2023
A Second Chance to Win Your Government Healthcare Contract Sheppard, Mullin, Richter & Hampton LLP
Mar
1
2015
A Second Look At The Innovation Act Obviousness Type Double Patenting Statute Foley & Lardner LLP
Jul
6
2013
A Short-Lived Victory for Generic Drug Manufacturers? Sheppard, Mullin, Richter & Hampton LLP
Jul
27
2020
A Shot Across the Bow of the Pharmaceutical Industry: President Trump Issues a Quartet of Executive Orders on Drug Pricing that Might Eventually (OR NEVER?) Take Effect Sheppard, Mullin, Richter & Hampton LLP
Jan
10
2020
A Simple Guide to Zantac Cancer Lawsuits and Settlements Stark & Stark
Apr
25
2019
A Special “Treatment” for Patent Eligibility McDermott Will & Emery
Feb
8
2011
A Sputnik Moment for Renewable Energy or Another Failed Launch? Michael Best & Friedrich LLP
Dec
2
2015
A Substantially Pure Isomer Is Obvious When the Completely Pure Isomer Is Known In The Art: Spectrum Pharms., Inc. v. Sandoz Inc. McDermott Will & Emery
Nov
14
2014
A Taste of Things to Come? Whole Foods Feels Sting of “Non-GMO” Litigation Mintz
Jul
19
2022
A Third Surge in Innovation and Patents on Hydrogen Fuel Cell Vehicles Foley & Lardner LLP
Mar
22
2016
A Time to Train: FDA Compliance Keller and Heckman LLP
Jun
22
2022
A Truly Piscatory Exemption Allen Matkins Leck Gamble Mallory & Natsis LLP
Jul
24
2013
A Two-fer: North Carolina Lawsuits Over Damage to Coastal Wetlands and Damage by Local Government Prayer Womble Bond Dickinson (US) LLP
Apr
24
2023
A UK Perspective on Dealing with Alcohol Dependence in the Workplace Vedder Price
Oct
5
2014
A Warehouse Full of Unapproved Genetically-Modified Seeds; Now What?, Syngenta Seeds, Inc. v. Bunge North America, Inc. McDermott Will & Emery
Jun
16
2020
A Warning to One, A Warning to All? ArentFox Schiff LLP
Aug
7
2023
A Watched Pot Never Boils: SAFE Banking on the Backburner Again Bradley Arant Boult Cummings LLP
Jan
3
2023
A Way Too Early Prediction: Alabama Cannabis 2.0 Bradley Arant Boult Cummings LLP
Sep
17
2019
A Win for Hemp in Court, and What it (Might) Mean for North Carolina Ward and Smith, P.A.
Dec
20
2023
A Win for Skinny Labels: Insights for Enforcing Use Patents Squire Patton Boggs (US) LLP
Apr
15
2024
A Win for the SEC on Shadow Trading. Now What? ArentFox Schiff LLP
Sep
30
2020
A Year of Living Dangerously: 2020 and Maneuvers on the 340B Drug Pricing Program Battlefield Sheppard, Mullin, Richter & Hampton LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins